نتائج البحث - Julie‐An Talano

  • يعرض 1 - 19 نتائج من 19
تنقيح النتائج
  1. 1
    Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art

    Allogeneic Hematopoietic Cell Transplantation for Chronic Granulomatous Disease: Controversies and State of the Art حسب James A. Connelly, Rebecca Marsh, Suhag Parikh, Julie‐An Talano

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell Disease

    Delayed Hemolytic Transfusion Reaction/Hyperhemolysis Syndrome in Children With Sickle Cell Disease حسب Julie‐An Talano, Cheryl A. Hillery, Jerome L. Gottschall, Diane M. Baylerian, James G. Scott

    منشور في 2003
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis

    Ruxolitinib for treatment of refractory hemophagocytic lymphohistiocytosis حسب Larisa Broglie, Lauren Pommert, Sridhar Rao, Monica S. Thakar, Rachel Phelan, David M. Margolis, Julie‐An Talano

    منشور في 2017
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Association of Crohn’s Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis

    Association of Crohn’s Disease, Thiopurines, and Primary Epstein-Barr Virus Infection with Hemophagocytic Lymphohistiocytosis حسب Vincent Biank, Mehul K. Sheth, Julie‐An Talano, David M. Margolis, Pippa Simpson, Subra Kugathasan, Michael C. Stephens

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassionate Use Study

    Efficacy and Safety of Ex Vivo Cultured Adult Human Mesenchymal Stem Cells (Prochymal™) in Pediatric Patients with Severe Refractory Acute Graft-Versus-Host Disease in a Compassion... حسب Vinod K. Prasad, Kenneth G. Lucas, Gary Kleiner, Julie‐An Talano, David A. Jacobsohn, Gloria Broadwater, Rod Monroy, Joanne Kurtzberg

    منشور في 2010
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Captopril to Mitigate Chronic Renal Failure After Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial

    Captopril to Mitigate Chronic Renal Failure After Hematopoietic Stem Cell Transplantation: A Randomized Controlled Trial حسب Eric P. Cohen, Amy A. Irving, William R. Drobyski, John P. Klein, Jakob Passweg, Julie‐An Talano, Mark Juckett, John E. Moulder

    منشور في 2007
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients

    Allogeneic Human Mesenchymal Stem Cell Therapy (Remestemcel-L, Prochymal) as a Rescue Agent for Severe Refractory Acute Graft-versus-Host Disease in Pediatric Patients حسب Joanne Kurtzberg, Susan E. Prockop, Pierre Teira, Henrique Bittencourt, Victor Lewis, Ka Wah Chan, Biljana Horn, Lolie C. Yu, Julie‐An Talano, Eneida R. Nemecek, Charles R. Mills, Sonali Chaudhury

    منشور في 2013
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and young adults with poor-risk refractory or recurrent Hodgkin and non-Hodgkin lymphoma

    Sequential myeloablative autologous stem cell transplantation and reduced intensity allogeneic hematopoietic cell transplantation is safe and feasible in children, adolescents and... حسب Prakash Satwani, Zhezhen Jin, Paul L. Martin, Monica Bhatia, James H. Garvin, D. George, Sonali Chaudhury, Julie‐An Talano, Erin Morris, Lauren Harrison, Jean Sosna, Margaret Peterson, Olga Militano, S. Foley, Joanne Kurtzberg, Mitchell S. Cairo

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders

    Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders حسب Lauri M. Burroughs, Akiko Shimamura, Julie‐An Talano, Jennifer Domm, Kelsey K. Baker, Colleen Delaney, Haydar Frangoul, David A. Margolis, K. Scott Baker, Eneida R. Nemecek, Amy E. Geddis, Brenda M. Sandmaier, H. Joachim Deeg, Rainer Storb, Ann E. Woolfrey

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial

    Treosulfan-Based Conditioning and Hematopoietic Cell Transplantation for Nonmalignant Diseases: A Prospective Multicenter Trial حسب Lauri M. Burroughs, Eneida R. Nemecek, Troy R. Torgerson, Barry E. Storer, Julie‐An Talano, Jennifer Domm, Roger Giller, Akiko Shimamura, Colleen Delaney, Suzanne Skoda‐Smith, Monica S. Thakar, K. Scott Baker, David J. Rawlings, Janet A. Englund, Mary E.D. Flowers, H. Joachim Deeg, Rainer Storb, Ann E. Woolfrey

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies

    Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies حسب Carl E. Allen, Rebecca Marsh, Peter Dawson, Catherine M. Bollard, Shalini Shenoy, Philip Roehrs, Rabi Hanna, Lauri M. Burroughs, Leslie S. Kean, Julie‐An Talano, Kirk R. Schultz, Sung‐Yun Pai, K. Scott Baker, Jeffrey R. Andolina, Elizabeth Stenger, James A. Connelly, Alyssa Ramirez, Christopher Bryant, Mary Eapen, Michael A. Pulsipher

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience

    Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience حسب Beatriz Morillo-Gutiérrez, Rita Beier, Kanchan Rao, Lauri M. Burroughs, Ansgar Schulz, Anna-Maria Ewins, Brenda Gibson, Petr Sedláček, Ladislav Król, Brigitte Strahm, Irina Zaidman, Krzysztof Kałwak, Julie‐An Talano, Ann E. Woolfrey, Chris Fraser, Isabelle Meyts, Ingo Müller, Jacek Wachowiak, Maria Ester Bernardo, Paul Veys, Karl-Walter Sykora, Andrew R. Gennery, Mary Slatter

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial

    Haploidentical bone marrow transplantation in patients with relapsed or refractory severe aplastic anaemia in the USA (BMT CTN 1502): a multicentre, single-arm, phase 2 trial حسب Amy E. DeZern, Mary Eapen, Juan Wu, Julie‐An Talano, Melhem Solh, Blachy J. Dávila Saldaña, Chatchada Karanes, Mitchell E. Horwitz, Kanwaldeep Mallhi, Sally Arai, Nosha Farhadfar, Elizabeth O. Hexner, Peter Westervelt, Joseph H. Antin, H. Joachim Deeg, Eric Leifer, Robert A. Brodsky, Brent R. Logan, Mary M. Horowitz, Richard J. Jones, Michael A. Pulsipher

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium

    Higher doses of tisagenlecleucel are associated with improved outcomes: a report from the pediatric real-world CAR consortium حسب Heather E. Stefanski, Anne Eaton, Christina Baggott, Jenna Rossoff, Michael R. Verneris, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Julie-An Talano, Amy Moskop, Steven Margossian, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, M. Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy

    Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy حسب Vanessa A. Fabrizio, Jaap Jan Boelens, Audrey Mauguen, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie‐An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz, Kevin J. Curran

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report

    Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report حسب Vanessa A. Fabrizio, Christine L. Phillips, Adam Lane, Christina Baggott, Snehit Prabhu, Emily Egeler, Sharon Mavroukakis, Holly Pacenta, Jenna Rossoff, Heather E. Stefanski, Julie‐An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vasant Chinnabhandar, Michael Kunicki, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Liora M. Schultz

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia

    Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia حسب Amy Moskop, Lauren Pommert, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie-An Talano, Steve P. Margossian, Michael R. Verneris, Gary D. Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Vasant Chinnabhandar, A. Yasemin Goksenin, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch, Erin Guest, Erin H. Breese, Liora M. Schultz

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report

    Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Conso... حسب Liora M. Schultz, Christina Baggott, Snehit Prabhu, Holly Pacenta, Christine L. Phillips, Jenna Rossoff, Heather E. Stefanski, Julie‐An Talano, Amy Moskop, Steven Margossian, Michael R. Verneris, Gary Douglas Myers, Nicole Karras, Patrick A. Brown, Muna Qayed, Michelle L. Hermiston, Prakash Satwani, Christa Krupski, Amy K. Keating, Rachel Wilcox, Cara A. Rabik, Vanessa A. Fabrizio, Rayne H. Rouce, Vasant Chinnabhandar, Michael Kunicki, Valentin Barsan, A. Yasemin Goksenin, Yimei Li, Sharon Mavroukakis, Emily Egeler, Kevin J. Curran, Crystal L. Mackall, Theodore W. Laetsch

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy

    Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Re... حسب Mohamed A. Kharfan‐Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori, Rebecca Marsh, Lauri M. Burroughs, Navneet S. Majhail, A. Samer Al‐Homsi, Zaid Al‐Kadhimi, Merav Bar, Alice Bertaina, Jaap Jan Boelens, Richard E. Champlin, Sonali Chaudhury, Zachariah DeFilipp, Bhagirathbhai Dholaria, Areej El‐Jawahri, Suzanne Fanning, Ellen Fraint, Usama Gergis, Sergio Giralt, Betty K. Hamilton, Shahrukh K. Hashmi, Biljana Horn, Yoshihiro Inamoto, David A. Jacobsohn, Tania Jain, Laura Johnston, Abraham S. Kanate, Ankit Kansagra, Adetola A. Kassim, Leslie S. Kean, Carrie L. Kitko, Jessica Knight‐Perry, Joanne Kurtzberg, Hien Liu, Margaret L. MacMillan, Zahra Mahmoudjafari, Marco Mielcarek, Mohamad Mohty, Arnon Nagler, Eneida R. Nemecek, Timothy S. Olson, Betül Oran, Miguel‐Angel Perales, Susan E. Prockop, Michael A. Pulsipher, Iskra Pusic, Marcie L. Riches, Cesar Rodriguez, Rizwan Romee, Gabriela Rondón, Ayman Saad, Nina Shah, Peter J. Shaw, Shalini Shenoy, Jorge Sierra, Julie‐An Talano, Michael R. Verneris, Paul Veys, John E. Wagner, Bipin N. Savani, Mehdi Hamadani, Paul A. Carpenter

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: